Sees FY25 revenue $3.1B-$3.2B, consensus $3.1B. Sees FY25 operating margin 32%-33% vs. 28.6% in FY24. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on BMRN: BioMarin reports Q4 non-GAAP EPS 92c, consensus 74c BMRN Upcoming Earnings Report: What to Expect? BioMarin stock undervalued at current levels, says JPMorgan BioMarin initiates legal action against Ascendis over patent infringement TD Cowen ‘disappointed’ Pfizer ended Sangamo collaboration